Pegloticase May Improve Uncontrolled Gout in Kidney Transplant Recipients
Investigators report findings from the PROTECT study assessing the efficacy and safety of pegloticase for uncontrolled gout among kidney transplant recipients.
Investigators report findings from the PROTECT study assessing the efficacy and safety of pegloticase for uncontrolled gout among kidney transplant recipients.
Investigators used dual-energy computed tomography to assess the extent of spinal monosodium urate deposition among patients with gout.
Researchers determined the association between obesity and the risk for incident gout, according to genetic predisposition, in individuals aged greater than 32 years, stratified by sex.
Researchers examine whether or not repeated serum urate testing produces a more accurate prediction of gout development.
Researchers studied the comparative efficacy and safety of urate-lowering therapy – allopurinol vs febuxostat – in the treatment of gout.
Researchers studied the association between genetic predisposition and diet on risk for incident gout among women.